These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16774486)

  • 1. Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.
    Ahmed MH; Saad RA; Osman MM
    Expert Opin Drug Saf; 2006 Jul; 5(4):487-8. PubMed ID: 16774486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease].
    Abel T; Fehér J; Dinya E; Gamal Eldin M; Kovács A
    Orv Hetil; 2009 May; 150(21):989-93. PubMed ID: 19443308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.
    Heart Advis; 2007 Jul; 10(7):7. PubMed ID: 17695657
    [No Abstract]   [Full Text] [Related]  

  • 4. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.
    Gryn SE; Hegele RA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1255-62. PubMed ID: 25920750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol drug controversy continues.
    Mitka M
    JAMA; 2008 May; 299(19):2266. PubMed ID: 18492963
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
    Galin ID; Smith DA
    Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
    [No Abstract]   [Full Text] [Related]  

  • 8. Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
    Mitka M
    JAMA; 2009 Feb; 301(8):813-5. PubMed ID: 19244181
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treats two sources of cholesterol.
    Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
    Davidson MH
    J Am Coll Cardiol; 2003 Jul; 42(2):398-9; author reply 399. PubMed ID: 12875794
    [No Abstract]   [Full Text] [Related]  

  • 11. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
    Derosa G; D'Angelo A; Franzetti IG; Ragonesi PD; Gadaleta G; Scalise F; Ciccarelli L; Piccinni MN; Cicero AF
    J Clin Pharm Ther; 2009 Jun; 34(3):267-76. PubMed ID: 19650249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin/ezetimibe combination therapy: emerging evidence.
    Kalhan A; Rees A
    Curr Opin Lipidol; 2011 Apr; 22(2):146-7. PubMed ID: 21415606
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.
    Ahmed MH; Byrne CD
    Diabetes Obes Metab; 2010 Nov; 12(11):958-66. PubMed ID: 20880342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
    Davidson MH
    Cleve Clin J Med; 2008 Jul; 75(7):479-82, 486-8, 490-1. PubMed ID: 18646584
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Schunn H
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2202; author reply 2202. PubMed ID: 20979010
    [No Abstract]   [Full Text] [Related]  

  • 20. Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia.
    Murdoch D; Scott LJ
    Am J Cardiovasc Drugs; 2004; 4(6):405-22. PubMed ID: 15554726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.